Universal Vision Biotechnology Co

Universal Vision Biotechnology Co EBITDA per Employee

The EBITDA per Employee of Universal Vision Biotechnology Co (3218.TWO) as of Oct 23, 2026 is 3.41 M TWD. In the previous year, EBITDA per Employee was 3.47 M TWD — a change of -1.89% (lower).

EBITDA per Employee

3.41 MTWD

YoY

-1.89%

Last updated:

EBITDA per Employee of Universal Vision Biotechnology Co is 2025 3.41 M TWD. EBITDA per Employee of Universal Vision Biotechnology Co was 2024 3.47 M TWD. It decreases by -1.89% lower compared to the previous year.

The Universal Vision Biotechnology Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
349,834.16 TWD
Jan 1, 2019
616,750.00 TWD
Jan 1, 2020
1.53 M TWD
Jan 1, 2021
1.93 M TWD
Jan 1, 2022
2.77 M TWD
Jan 1, 2023
3.32 M TWD
Jan 1, 2024
3.47 M TWD
Jan 1, 2025
3.41 M TWD
The Universal Vision Biotechnology Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
3.41 MTWD-1.89%
3.47 MTWD+4.51%
3.32 MTWD+20.17%
2.77 MTWD+43.10%
1.93 MTWD+26.67%
1.53 MTWD+147.46%
616,750.00TWD+76.30%
349,834.16TWD+9.59%
319,215.35TWD+13.44%
281,393.56TWD+23.34%
228,136.14TWD-6.03%
242,769.80TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co., Ltd. generates revenue through the sale of optical instruments, glasses, contact lenses, and glass ornaments. The company also provides laser vision correction equipment and services, trades medical drugs, and offers leasing of medical facilities, clinic operation planning, and medical cosmetology services. Its primary market is Taiwan, where it serves customers seeking vision correction solutions and medical aesthetic treatments. The firm's product portfolio includes optical instruments, glasses, contact lenses, and glass ornaments, alongside medical drug trading. Services such as laser vision correction, medical facility leasing, clinic operation planning, and medical cosmetology are key revenue drivers. Taiwan-based customers, including individuals requiring vision care and clinics needing operational support, form the core market segment. Revenue streams are derived from the direct sale of optical products, medical drug trading, and service-based offerings like laser vision correction and medical cosmetology. The company operates exclusively within Taiwan, focusing on both consumer and clinic-level clients for its comprehensive vision and medical aesthetics solutions. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

EBITDA per Employee of Universal Vision Biotechnology Co is 3.41 M TWD in 2025.

EBITDA per Employee of Universal Vision Biotechnology Co changed from 3.47 M TWD to 3.41 M TWD, representing a -1.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Universal Vision Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Universal Vision Biotechnology Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Universal Vision Biotechnology Co